Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex
- PMID: 1393263
- PMCID: PMC1907491
- DOI: 10.1111/j.1476-5381.1992.tb14331.x
Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex
Abstract
1. The effects of blockers and openers of K+ channels on binding of [3H]-glibenclamide to microsomes obtained from a pancreatic beta-cell line (HIT-T15) or rat cerebral cortex were examined. 2. The blockers quinine, chlorpromazine and thiopentone and the openers cromakalim [(+/- ) 6-cyano-3,4-dihydro-2,2-dimethyl-trans-4-(2-oxo-1- pyrrolidyl)-2H-benzo[b]pyran-3-ol] and minoxidil sulphate did not significantly interact with the sulphonylurea receptor of HIT-cells both at phosphorylating (presence of MgATP) and dephosphorylating (absence of MgATP) conditions. 3. In the absence of MgATP, pinacidil (200-500 microM) did not significantly displace [3H]-glibenclamide binding to microsomes from HIT-cells. The displacement of [3H]-glibenclamide binding was strongly enhanced by MgATP and was due to a decrease in the number of high affinity binding sites for glibenclamide. 4. MgATP enhanced pinacidil-induced inhibition of [3H]-glibenclamide binding to microsomes from rat cerebral cortex. 5. The effect of MgATP on pinacidil-induced inhibition of [3H]-glibenclamide binding was maintained after solubilization of the membranes from HIT-cells or rat cerebral cortex. 6. It is concluded that the sulphonylurea receptor is regulated not only by sulphonylureas but also by the K+ channel openers, diazoxide and pinacidil, and by protein phosphorylation. The binding sites for sulphonylureas and these K+ channel openers are not identical, but appear to be located at a single protein or at tightly associated proteins.
Similar articles
-
Possible involvement of protein phosphorylation in the regulation of the sulphonylurea receptor of a pancreatic beta-cell line, HIT T15.Biochim Biophys Acta. 1991 Dec 3;1133(1):95-101. doi: 10.1016/0167-4889(91)90246-t. Biochim Biophys Acta. 1991. PMID: 1836360
-
The binding properties of the solubilized sulfonylurea receptor from a pancreatic B-cell line are modulated by the Mg(++)-complex of ATP.J Pharmacol Exp Ther. 1992 Aug;262(2):495-502. J Pharmacol Exp Ther. 1992. PMID: 1501109
-
Characterization and solubilization of the sulphonylurea receptor in rat brain.Neuropharmacology. 1993 Oct;32(10):951-7. doi: 10.1016/0028-3908(93)90059-c. Neuropharmacology. 1993. PMID: 8295717
-
The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.Diabetes Res Clin Pract. 1995 Aug;28 Suppl:S67-80. doi: 10.1016/0168-8227(95)01076-p. Diabetes Res Clin Pract. 1995. PMID: 8529521 Review.
-
Protein phosphorylation and beta-cell function.Diabetologia. 1994 Sep;37 Suppl 2:S21-9. doi: 10.1007/BF00400822. Diabetologia. 1994. PMID: 7821735 Review.
Cited by
-
Binding and effect of K ATP channel openers in the absence of Mg2+.Br J Pharmacol. 2003 May;139(2):368-80. doi: 10.1038/sj.bjp.0705238. Br J Pharmacol. 2003. PMID: 12770942 Free PMC article.
-
Location of the sulphonylurea receptor at the cytoplasmic face of the beta-cell membrane.Br J Pharmacol. 1994 Nov;113(3):903-11. doi: 10.1111/j.1476-5381.1994.tb17078.x. Br J Pharmacol. 1994. PMID: 7858884 Free PMC article.
-
KATP channel openers of the benzopyran type reach their binding site via the cytosol.Br J Pharmacol. 2006 Sep;149(2):199-205. doi: 10.1038/sj.bjp.0706858. Epub 2006 Aug 14. Br J Pharmacol. 2006. PMID: 16921394 Free PMC article.
-
Interaction of tolbutamide and cytosolic nucleotides in controlling the ATP-sensitive K+ channel in mouse beta-cells.Br J Pharmacol. 1994 Jan;111(1):302-10. doi: 10.1111/j.1476-5381.1994.tb14060.x. Br J Pharmacol. 1994. PMID: 8012711 Free PMC article.
-
Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans.Diabetologia. 1996 Sep;39(9):1083-90. doi: 10.1007/BF00400658. Diabetologia. 1996. PMID: 8877293 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources